2,3-Difluorobenzenethiol
CAS: 130922-39-3
Ref. 3D-FD77841
10mg | Descontinuado | ||
25mg | Descontinuado | ||
50mg | Descontinuado | ||
100mg | Descontinuado | ||
250mg | Descontinuado |
Informação sobre produto
2,3-Difluorobenzenethiol is a triazolopyrimidine that is currently in the preclinical phase of development for the treatment of cancer. It has been shown to have an antagonist effect on the pharmacological activity of pyrazolopyrimidines. The systematic optimization and pharmacokinetic properties of 2,3-difluorobenzenethiol have been studied extensively. This drug is orally bioavailable and has good pharmacological properties.